HOME › DRUGS › SOFOSBUVIR;VELPATASVIR
ACTIVE SUBSTANCE / INN

SOFOSBUVIR;VELPATASVIR

Brand name(s): Epclusa
EMA LISTED
AUTHORISED
Hepatitis C, Chronic
ACTIVE SUBSTANCE
Sofosbuvir;Velpatasvir
REGULATORS
EMA
SPONSORS / MAH
Gilead Sciences Ireland UC
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
EpclusaGilead Sciences Ireland UCAuthorised06/07/2016Hepatitis C, Chronic

FULL INTELLIGENCE ON SOFOSBUVIR;VELPATASVIR

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →